{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0090303",
      "entity_text" : "injury",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01335",
      "entity_text" : "H9C2",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "To investigate whether Cx43 is involved in PFD regulated protection against Hcy induced H9C2 cell injury, H9C2 cardiomyocytes were pre-treated with the Cx43 agonist, AAP10 (50 nmol/l, 1 h) and Hcy for the following experiments.",
  "reading_complete" : "2020-08-03T13:35:47Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T13:35:04Z",
  "trigger" : "induced",
  "evidence" : [ "induced H9C2 cell injury, H9C2" ],
  "pmc_id" : "7053877",
  "score" : 0
}